Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line

World Journal of Gastroenterology

Volumn 11, Issue 28, 2005, Pages 4337-4343

  Gao, Xue Qin ^a,b   Han, Jin Xiang ^a,b   Huang, Hai Yan ^a   Song, Bao ^a   Zhu, Bo ^a   Song, Chang Zheng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

cDNA microarray; Colorectal cancer gene expression; Metastasis; NS398

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; GROWTH FACTOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C JUN; RNA; SOMATOMEDIN BINDING PROTEIN 5; TRANSCRIPTION FACTOR REL;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DNA RNA HYBRIDIZATION; DOWN REGULATION; DRUG EFFECT; DRUG TARGETING; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; NUCLEOTIDE SEQUENCE; ONCOGENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; VALIDATION PROCESS;

EID: 23244435876     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i28.4337     Document Type: Article

References (28)

1. Li M, Wu X, Xu XC. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clini Cancer Res 2001; 7: 1010-1016
2. Hung WC, Chang HC, Pan MR, Lee TH, Chuang LY. Induction of p27(KIP1) as a mechanisms underlying NS398-induced growth inhibition in hung cancer cells. Mol Pharmacol 2000; 58: 1398-1403
3. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 1999; 17: 687-694
4. Attiga FA, Fernandez PM, Weeraratna AT, Manyak Michael MJ, Patierno SR. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 2000; 60: 4629-4637
5. Pan MR, Chuang LY, Hung WC. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells. FEBS Lett 2001; 508: 365-368
6. Liu LT, Chang HC, Chiang LC, Hung WC. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells. Oncogene 2002; 21: 8347-8350
7. DNA precipitations/Preparation of DNA samples. [Last Update, December1999] [Bioinformatics Manual]. Available from: http://cmgm.stanford.edu/pbrown/protocols/2_DNA.html
8. Post-processing of arrays/Experimental Protocols [updated September 1999] http://www.cmgm.stanford.edu/pbrown/protocols/3_post_process.html
9. Hasseman JP. Aminoallyl labeling of RNA for microarray. Revision Level:2 (http://pga.tigr.org/sop/Moo4_1a.pdf)
10. Yang IV, Chen E, Hasseman JP, Liang W, Frank BC, Wang SB, Sharov V, Saeed AI, White J, Li J, Lee NH, Yeatman TJ, Quackenbush J. Within the fold: assessing differential expression measures and reproductivity in microarray assays. Genome Biol 2002; 3: 1-12
11. Bushman TL, Kuemmerle JF. IGFBP-3 and IGFBP-5 production by human intestinal muscle: recipriocal regulation by endogeneous TGF-β1. Am J Phsiol 1998; 275(6 Pt 1): G1282-G1290
12. Amirghahari N, Harrison L, Smith M, Rong X, Naumann I, Ampil F, Shi R, Glass J, Nathan CA. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. Int J Radiat Oncol Biol Phys 2003; 57: 1405-1412
13. Peng JP, Liu LT, Chang HC, Hung WC. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells. Cancer Lett 2003; 201: 157-163
14. Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J. Cyclooxygenase-2 inhibitor NS398 enhances anti-tumor effect of irradiation on hormone refractory human prostate carcinoma cells. J Urol 2003; 170: 2036-2039
15. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014: 155-163
16. Seidel B, Braeg S, Adler G, Wedlich D, Menke A. E- and N-cadherin differ with respect to their associated p120(ctn) isoforms and their ability to suppress invasive growth in pancreatic cancer cells. Oncogene 2004; 23: 5532-5542
17. Kovacs A, Dhillon J, Walker RA. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 2003; 56: 318-322
18. Butt AJ, Dickson KA, McDougall F, Baxter RC. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 2003; 278: 29676-29685
19. Stolf BS, Carvalho AF, Martins WK, Runza FB, Brun M, Hirata R Jr, Jordao Neves E, Soares FA, Postigo-Dias J, Kowalski LP, Reis LF. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett 2003; 191: 193-202
20. Nordqvist AC, Mathiesen T. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002; 57: 19-26
21. McCaig C, Perks CM, Holly JM. Signaling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival. J Cell Biochem 2002; 84: 784-794
22. Lee BP, Rushlow WJ, Chakraborty C, Lala PK. Differential gene expression in premalignant human trophoblast: role of IGFBP-5. Int J Cancer 2001; 94: 674-684
23. Yi HK, Hwang PH, Yang DH, Kang CW, Lee DY. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 2001; 37: 2257-2263
24. Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S, Wolf E, Lahm H. Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem Biophys Res Commun 2001; 288: 435-442
25. Hourihan RN, O'Sullivan GC, Morgan JG. Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 2003; 23: 161-165
26. Hasina R, Hulett K, Bicciato S, Di Bello C, Petruzzelli GJ, Lingen MW. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Res 2003; 63: 555-559
27. Bernard-Gallon DJ, Peffault de Latour M, Hizel C, Vissac C, Cure H, Pezet D, Dechelotte PJ, Chipponi J, Chassagne J, Bignon YJ. Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas. Anticancer Res 2001; 21: 2011-2020
28. Bieche I, Tozlu S, Girault I, Lidereau R. Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Mol Cancer 2004; 3: 37